Nishant Sinha1, Yujiang Wang2, Nádia Moreira da Silva2, Anna Miserocchi2, Andrew W McEvoy2, Jane de Tisi2, Sjoerd B Vos2, Gavin P Winston2, John S Duncan2, Peter N Taylor2. 1. From the Translational and Clinical Research Institute (N.S.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (N.S., Y.W., N.M.d.S., P.N.T.), Interdisciplinary Computing and Complex BioSystems Group, School of Computing, Newcastle University, Newcastle Upon Tyne; NIHR University College London Hospitals Biomedical Research Centre (Y.W., A.M., A.W.M., J.d.T., S.B.V., G.P.W., J.S.D., P.N.T.), UCL Institute of Neurology, Queen Square; Centre for Medical Image Computing (S.B.V.), University College London; Epilepsy Society MRI Unit (S.B.V., G.P.W., J.S.D), Chalfont St Peter, UK; and Department of Medicine (G.P.W.,), Division of Neurology, Queen's University, Kingston, Ontario, Canada. nishant.sinha89@gmail.com Peter.taylor@newcastle.ac.uk. 2. From the Translational and Clinical Research Institute (N.S.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (N.S., Y.W., N.M.d.S., P.N.T.), Interdisciplinary Computing and Complex BioSystems Group, School of Computing, Newcastle University, Newcastle Upon Tyne; NIHR University College London Hospitals Biomedical Research Centre (Y.W., A.M., A.W.M., J.d.T., S.B.V., G.P.W., J.S.D., P.N.T.), UCL Institute of Neurology, Queen Square; Centre for Medical Image Computing (S.B.V.), University College London; Epilepsy Society MRI Unit (S.B.V., G.P.W., J.S.D), Chalfont St Peter, UK; and Department of Medicine (G.P.W.,), Division of Neurology, Queen's University, Kingston, Ontario, Canada.
Abstract
OBJECTIVE: We assessed preoperative structural brain networks and clinical characteristics of patients with drug-resistant temporal lobe epilepsy (TLE) to identify correlates of postsurgical seizure recurrences. METHODS: We examined data from 51 patients with TLE who underwent anterior temporal lobe resection (ATLR) and 29 healthy controls. For each patient, using the preoperative structural, diffusion, and postoperative structural MRI, we generated 2 networks: presurgery network and surgically spared network. Standardizing these networks with respect to controls, we determined the number of abnormal nodes before surgery and expected to be spared by surgery. We incorporated these 2 abnormality measures and 13 commonly acquired clinical data from each patient into a robust machine learning framework to estimate patient-specific chances of seizures persisting after surgery. RESULTS: Patients with more abnormal nodes had a lower chance of complete seizure freedom at 1 year and, even if seizure-free at 1 year, were more likely to relapse within 5 years. The number of abnormal nodes was greater and their locations more widespread in the surgically spared networks of patients with poor outcome than in patients with good outcome. We achieved an area under the curve of 0.84 ± 0.06 and specificity of 0.89 ± 0.09 in predicting unsuccessful seizure outcomes (International League Against Epilepsy [ILAE] 3-5) as opposed to complete seizure freedom (ILAE 1) at 1 year. Moreover, the model-predicted likelihood of seizure relapse was significantly correlated with the grade of surgical outcome at year 1 and associated with relapses up to 5 years after surgery. CONCLUSION: Node abnormality offers a personalized, noninvasive marker that can be combined with clinical data to better estimate the chances of seizure freedom at 1 year and subsequent relapse up to 5 years after ATLR. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that node abnormality predicts postsurgical seizure recurrence.
OBJECTIVE: We assessed preoperative structural brain networks and clinical characteristics of patients with drug-resistant temporal lobe epilepsy (TLE) to identify correlates of postsurgical seizure recurrences. METHODS: We examined data from 51 patients with TLE who underwent anterior temporal lobe resection (ATLR) and 29 healthy controls. For each patient, using the preoperative structural, diffusion, and postoperative structural MRI, we generated 2 networks: presurgery network and surgically spared network. Standardizing these networks with respect to controls, we determined the number of abnormal nodes before surgery and expected to be spared by surgery. We incorporated these 2 abnormality measures and 13 commonly acquired clinical data from each patient into a robust machine learning framework to estimate patient-specific chances of seizures persisting after surgery. RESULTS: Patients with more abnormal nodes had a lower chance of complete seizure freedom at 1 year and, even if seizure-free at 1 year, were more likely to relapse within 5 years. The number of abnormal nodes was greater and their locations more widespread in the surgically spared networks of patients with poor outcome than in patients with good outcome. We achieved an area under the curve of 0.84 ± 0.06 and specificity of 0.89 ± 0.09 in predicting unsuccessful seizure outcomes (International League Against Epilepsy [ILAE] 3-5) as opposed to complete seizure freedom (ILAE 1) at 1 year. Moreover, the model-predicted likelihood of seizure relapse was significantly correlated with the grade of surgical outcome at year 1 and associated with relapses up to 5 years after surgery. CONCLUSION: Node abnormality offers a personalized, noninvasive marker that can be combined with clinical data to better estimate the chances of seizure freedom at 1 year and subsequent relapse up to 5 years after ATLR. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that node abnormality predicts postsurgical seizure recurrence.
Authors: Jane de Tisi; Gail S Bell; Janet L Peacock; Andrew W McEvoy; William F J Harkness; Josemir W Sander; John S Duncan Journal: Lancet Date: 2011-10-15 Impact factor: 79.321
Authors: Victoria L Morgan; Dario J Englot; Baxter P Rogers; Bennett A Landman; Ahmet Cakir; Bassel W Abou-Khalil; Adam W Anderson Journal: Epilepsia Date: 2017-04-27 Impact factor: 5.864
Authors: Carrie R McDonald; Donald J Hagler; Mazyar E Ahmadi; Evelyn Tecoma; Vicente Iragui; Lusineh Gharapetian; Anders M Dale; Eric Halgren Journal: Epilepsia Date: 2008-02-07 Impact factor: 5.864
Authors: Brent C Munsell; Chong-Yaw Wee; Simon S Keller; Bernd Weber; Christian Elger; Laura Angelica Tomaz da Silva; Travis Nesland; Martin Styner; Dinggang Shen; Leonardo Bonilha Journal: Neuroimage Date: 2015-06-06 Impact factor: 6.556
Authors: Vejay N Vakharia; John S Duncan; Juri-Alexander Witt; Christian E Elger; Richard Staba; Jerome Engel Journal: Ann Neurol Date: 2018-04-10 Impact factor: 10.422
Authors: Shennan A Weiss; Tomas Pastore; Iren Orosz; Daniel Rubinstein; Richard Gorniak; Zachary Waldman; Itzhak Fried; Chengyuan Wu; Ashwini Sharan; Diego Slezak; Gregory Worrell; Jerome Engel; Michael R Sperling; Richard J Staba Journal: Brain Commun Date: 2022-04-20
Authors: Nishant Sinha; Natalie Peternell; Gabrielle M Schroeder; Jane de Tisi; Sjoerd B Vos; Gavin P Winston; John S Duncan; Yujiang Wang; Peter N Taylor Journal: Epilepsia Date: 2021-01-21 Impact factor: 6.740
Authors: Peter N Taylor; Christoforos A Papasavvas; Thomas W Owen; Gabrielle M Schroeder; Frances E Hutchings; Fahmida A Chowdhury; Beate Diehl; John S Duncan; Andrew W McEvoy; Anna Miserocchi; Jane de Tisi; Sjoerd B Vos; Matthew C Walker; Yujiang Wang Journal: Brain Date: 2022-04-29 Impact factor: 15.255
Authors: Jonathan J Horsley; Gabrielle M Schroeder; Rhys H Thomas; Jane de Tisi; Sjoerd B Vos; Gavin P Winston; John S Duncan; Yujiang Wang; Peter N Taylor Journal: Neuroimage Clin Date: 2022-07-09 Impact factor: 4.891